Clinical Trial Update: A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness [Phase 3]

View source ↗

Summary

Phase 3, double-masked trial comparing FID 123320 ophthalmic solution to vehicle for reducing ocular redness has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Redness

Drugs mentioned

• FID 123320 Ophthalmic Solution

Snippet

Sponsor: Alcon Research | Conditions: Ocular Redness | Phase 3 | Status: COMPLETED